Sepsis is a systemic inflammatory response that can result in cardiac insufficiency or heart failure known as septic myocardial injury. A previous study identified OLFM4 as an important gene in sepsis through bioinformatics analysis. However, there is limited research on the regulatory functions of OLFM4 in sepsis-triggered myocardial injury, and the related molecular mechanisms remain unclear. In this study, the protein expression of OLFM4 was found to be significantly elevated in LPS-stimulated H9C2 cells, and its suppression enhanced cell proliferation and reduced cell apoptosis in LPS-triggered H9C2 cells. The inflammatory factors TNF-α, IL-6, and IL-1β were increased after LPS treatment, and these effects were mitigated after silencing OLFM4. Moreover, it was confirmed that inhibition of OLFM4 attenuated the NF-κB signaling pathway. In conclusion, the knockdown of OLFM4 protected cardiomyocytes from sepsis by inhibiting apoptosis and inflammatory responses via the NF-κB pathway. These findings provide important insights into the regulatory functions of OLFM4 in the progression of septic myocardial injury.
Keyphrases
- signaling pathway
- cell cycle arrest
- pi k akt
- acute kidney injury
- inflammatory response
- induced apoptosis
- septic shock
- cell proliferation
- oxidative stress
- intensive care unit
- lps induced
- endoplasmic reticulum stress
- heart failure
- cell death
- epithelial mesenchymal transition
- left ventricular
- anti inflammatory
- transcription factor
- dna methylation
- gene expression
- bioinformatics analysis
- cell cycle
- genome wide
- immune response
- cardiac resynchronization therapy
- replacement therapy